These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. NOTCH1 signaling as a therapeutic target in Sézary syndrome. van der Fits L; Qin Y; Out-Luiting JJ; Vermeer KG; Whittaker S; van Es JH; Tensen CP; Vermeer MH J Invest Dermatol; 2012 Dec; 132(12):2810-7. PubMed ID: 22718117 [TBL] [Abstract][Full Text] [Related]
25. Novel Mutations Involving NF-κB and B-Cell Signaling Pathways in Primary Cutaneous Large B-Cell Lymphoma, Leg-Type and Comparison with Sézary Syndrome. Kim EJ; Lewis DJ; Duvic M J Invest Dermatol; 2017 Sep; 137(9):1831-1833. PubMed ID: 28843295 [TBL] [Abstract][Full Text] [Related]
26. Novel MYBL1 Gene Rearrangements with Recurrent MYBL1-NFIB Fusions in Salivary Adenoid Cystic Carcinomas Lacking t(6;9) Translocations. Mitani Y; Liu B; Rao PH; Borra VJ; Zafereo M; Weber RS; Kies M; Lozano G; Futreal PA; Caulin C; El-Naggar AK Clin Cancer Res; 2016 Feb; 22(3):725-33. PubMed ID: 26631609 [TBL] [Abstract][Full Text] [Related]
27. Loss of β-arrestin-2 gene and possible functional consequences on Sezary Syndrome. Cristofoletti C; Bresin A; Caprini E; Russo G; Narducci MG Cell Cycle; 2019 Jun; 18(11):1292-1294. PubMed ID: 31106661 [TBL] [Abstract][Full Text] [Related]
28. EPHA4 is overexpressed but not functionally active in Sézary syndrome. Hameetman L; van der Fits L; Zoutman WH; Out-Luiting JJ; Siegal G; de Esch IJ; Vermeer MH; Tensen CP Oncotarget; 2015 Oct; 6(31):31868-76. PubMed ID: 26376612 [TBL] [Abstract][Full Text] [Related]
29. Genomic analysis of mycosis fungoides and Sézary syndrome identifies recurrent alterations in TNFR2. Ungewickell A; Bhaduri A; Rios E; Reuter J; Lee CS; Mah A; Zehnder A; Ohgami R; Kulkarni S; Armstrong R; Weng WK; Gratzinger D; Tavallaee M; Rook A; Snyder M; Kim Y; Khavari PA Nat Genet; 2015 Sep; 47(9):1056-60. PubMed ID: 26258847 [TBL] [Abstract][Full Text] [Related]
30. Downregulation of Fas gene expression in Sézary syndrome is associated with promoter hypermethylation. Jones CL; Wain EM; Chu CC; Tosi I; Foster R; McKenzie RC; Whittaker SJ; Mitchell TJ J Invest Dermatol; 2010 Apr; 130(4):1116-25. PubMed ID: 19759548 [TBL] [Abstract][Full Text] [Related]
31. Sézary syndrome is a unique cutaneous T-cell lymphoma as identified by an expanded gene signature including diagnostic marker molecules CDO1 and DNM3. Booken N; Gratchev A; Utikal J; Weiss C; Yu X; Qadoumi M; Schmuth M; Sepp N; Nashan D; Rass K; Tüting T; Assaf C; Dippel E; Stadler R; Klemke CD; Goerdt S Leukemia; 2008 Feb; 22(2):393-9. PubMed ID: 18033314 [TBL] [Abstract][Full Text] [Related]